March 24, 2022 by Chain Drug Review
APhA
Leading Headlines, Pharmacy

WASHINGTON — To ensure Medicare patients can continue to access essential care and services provided by pharmacists, the American Pharmacists Association (APhA), a lead partner in the Future of Pharmacy Care Coalition, strongly supports the Equitable Community Access to Pharmacist Services Act (ECAPS). The bill was introduced by Congressman Ron Kind (D, Wis.), Congressman David
October 14, 2020 by Chain Drug Review
APhA, Marialice Bennett, Remington Honor Medal
Leading Headlines, Pharmacy

WASHINGTON — Ohio State University (OSU) College of Pharmacy professor emeritus Marialice Bennett has received the 2021 Remington Honor Medal, the highest recognition bestowed by the American Pharmacists Association (APhA). Bennett, the seventh woman to be recognized since the Remington medal’s inception in 1919, retired as the director of the Community and Ambulatory Care Residency
September 9, 2020 by Chain Drug Review
APhA, COVID-19 vaccine, Department of Health and Human Services' (HHS) proposed rule permitting prescription drug importation, Scott Knoer
Leading Headlines, Pharmacy

WASHINGTON — The U.S. Department of Health and Human Services (HHS) authorized pharmacists and pharmacist interns to order and administer COVID-19 vaccines that have been approved or licensed by the Food and Drug Administration (FDA) to all individuals age 3 or older. Pharmacist interns must do so while acting under the supervision of qualified pharmacist.
June 23, 2020 by Chain Drug Review
addressing structural racism in pharmacy, Andrew Gentles, APhA, Scott Knoer
Leading Headlines, Pharmacy

WASHINGTON — The APhA board of trustees has taken a critical next step in addressing structural racism in pharmacy by appointing a diverse group of APhA members to provide input and guidance to the APhA board and staff. The task force will recommend actions driving short- and long-term strategies to eliminate racism, discrimination, injustice, and
June 1, 2020 by Chain Drug Review
APhA, Scott Knoer, Thomas Menighan
Leading Headlines, Pharmacy

WASHINGTON — Scott Knoer was sworn in Monday as the 13th chief executive officer and executive vice president of the American Pharmacists Association, during a virtual ceremony witnessed by APhA members and staff. “Being sworn in as the leader of this storied organization is the greatest honor of my life. Guiding our profession through a
May 8, 2020 by Chain Drug Review
APhA, ASCP, DIR fees, FMI, NACDS, NASP, NASPA, NCPA
Leading Headlines, Pharmacy

WASHINGTON – More than 240 patient advocates and healthcare entities on Friday urged Congressional leaders to act now on a key reform to lower patients’ prescription drug prices at the pharmacy counter and to help prevent pharmacy closures that jeopardize access for vulnerable Americans. “Members of Congress should not overlook the clear and present opportunity to
June 10, 2019 by Chain Drug Review
APhA, DIR Reform, FMI, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”, NACDS, NASP, NCPA, NGA
Leading Headlines, Pharmacy

WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to
June 3, 2019 by Chain Drug Review
Alex Gourlay, APhA, Walgreens Boots Aliance
June 3, 2019, News

DEERFIELD, Ill. — Walgreens this month announced it will train some of its pharmacists and other employees in understanding risk factors and warning signs for mental health and addiction concerns as well as strategies for helping individuals in crisis and noncrisis situations. Walgreens said its participation in the Mental Health First Aid program will be
August 11, 2017 by Bill Schiffner
American Pharmacists Association, American Pharmacists Month, APhA, Leadership360 Institute, Manage360, Mentor360, Thomas Menighan
Pharmacy, Retail News

WASHINGTON — The American Pharmacists Association (APhA) has unveiled the Leadership360 Institute, an educational program to help pharmacists enhance their leadership and management skills. Institute participants can sign up for any or all of the three Leadership tracks, including Lead360, Mentor360 and Manage360. Each track will offer programs to help pharmacists excel in their individual
February 1, 2017 by CDR Blog and Chain Drug Review
American Pharmacists Association, APhA, Department of Health and Human Services, Donald Trump, HHS secretary nominee, Pharmacy and Medically Underserved Areas Enhancement Act, provider status, Tom Menighan, Tom Price
CDR Blog

Rep. Tom Price (R., Ga.) had a tense confirmation hearing in the Senate last week for his nomination by President Donald Trump as secretary of the Department of Health and Human Services (HHS). But he got a thumbs-up from the American Pharmacists Association (APhA) on at least one count: pharmacists’ place in the U.S. health
September 16, 2016 by Chain Drug Review
American Pharmacists Association, APhA, Austin Scott, Dave Loebsack, Doug Collins, Earl "Buddy" Carter, H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act, pharmacy provider status, S. 314, video
Videos

(*Note: Segment begins at 00:21 of clip. Video courtesy of C-Span.) Earlier this week, several congressman voice their support for the pharmacy profession on the floor of the House of Representatives, the American Pharmacists Association (APhA) reported. Speaking during an hour-long Special Order on pharmacy issues, Rep. Earl “Buddy” Carter (R., Ga.) — the only
August 2, 2016 by Chain Drug Review
American Pharmacists Association, APhA, biologic drugs, biosimilars, FDA and NIH Workforce Authorities Modernization Act, S. 2700, Stacie Maass, U.S. Pharmacopeia, USP
Leading Headlines, Pharmacy, Retail News

WASHINGTON — A coalition of pharmacy industry organizations has asked congressional leaders to weigh proposals that would free certain biologic drugs from adherence to U.S. Pharmacopeia (USP) standards. This week, the American Pharmacists Association (APhA) and eight other groups sent a letter to the chairman and ranking members of key House and Senate committees expressing
July 18, 2016 by Chain Drug Review and Chain Drug Review
American Pharmacists Association, Amgen, APhA, APhA Academy of Student Pharmacists, APhA-ASP, APhA-ASP Summer Leadership Institute, Cardinal Health, Rite Aid
Leading Headlines, Pharmacy, Retail News

WASHINGTON — Over the weekend, the American Pharmacists Association (APhA) gave pharmacy students an opportunity for their voices to be heard on Capitol Hill. The APhA Academy of Student Pharmacists (APhA-ASP), supported by Rite Aid, Cardinal Health and Amgen, hosted leadership and professional development programming in Washington, D.C., for 240 pharmacy students. Running Friday to
June 24, 2016 by Chain Drug Review
American Pharmacists Association, APhA, H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act, Ron Kind, S. 314, Thomas Menighan, Todd Young
Leading Headlines, Pharmacy, Retail News, Uncategorized

WASHINGTON — The American Pharmacists Association (APhA) applauded remarks by two congressmen in support of pharmacist provider status legislation. APhA said Reps. Ron Kind (D., Wis.) and Todd Young (R., Ind.) issued statements this week to the House Ways and Means Subcommittee on Health calling for pharmacists to have a bigger role in health care.